Atrophy and degeneration in sciatic nerve of presymptomatic mice carrying the Huntington's disease mutation

Brain Research

Volumn 1188, Issue 1, 2008, Pages 61-68

  Wade, Anna ^a   Jacobs, Peter ^a   Morton, A Jennifer ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Axon; Polyglutamine repeat; R6 2 mice; Skeletal muscle; Wallerian degeneration

Indexed keywords

MYELIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AXOPLASM; BRAIN ATROPHY; CELL LOSS; CELL SIZE; CELL ULTRASTRUCTURE; CONTROLLED STUDY; GENE MUTATION; HUNTINGTON CHOREA; MOTOR DYSFUNCTION; MOUSE; MYELINATED NERVE; NERVE DEGENERATION; NERVE FIBER; NEUROMUSCULAR SYNAPSE; NEUROPATHOLOGY; NONHUMAN; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; SCIATIC NERVE; THICKNESS; WILD TYPE;

ANIMALS; AXONS; BRAIN; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; HUNTINGTON DISEASE; MICE; MICE, INBRED C57BL; MICE, INBRED CBA; MICE, NEUROLOGIC MUTANTS; MICE, TRANSGENIC; MICROSCOPY, ELECTRON, TRANSMISSION; MUSCLE, SKELETAL; MUSCULAR ATROPHY; NERVE FIBERS, MYELINATED; NEUROMUSCULAR JUNCTION; NEUROMUSCULAR JUNCTION DISEASES; PERIPHERAL NERVOUS SYSTEM DISEASES; PHENOTYPE; SCIATIC NERVE; SCIATIC NEUROPATHY; WALLERIAN DEGENERATION;

ANIMALIA; MUS; MUS MUSCULUS; WALLERIA;

EID: 37349066159     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2007.06.059     Document Type: Article

References (48)

1. Bates G.P., Harper P.S., and Jones L. Huntington's Disease. 3rd Edition (2002), Oxford University Press Ltd, Oxford
2. Beglinger L.J., Nopoulos P.C., Jorge R.E., Langbehn D.R., Mikos A.E., Moser D.J., Duff K., Robinson R.G., and Paulsen J.S. White matter volume and cognitive dysfunction in early Huntington's disease. Cogn. Behav. Neurol. 18 (2005) 102-107
3. Bossy-Wetzel E., Schwarzenbacher R., and Lipton S.A. Molecular pathways to neurodegeneration. Nat. Med. 10 (2004) S2-S9 (Suppl)
4. Carter R.J., Lione L.A., Humby T., Mangiarini L., Mahal A., Bates G.P., Dunnett S.B., and Morton A.J. Characterization of progressive motor deficits in mice transgenic for the human Huntington's disease mutation. J. Neurosci. 19 (1999) 3248-3257
5. Charrin B.C., Saudou F., and Humbert S. Axonal transport failure in neurodegenerative disorders: the case of Huntington's disease. Pathol. Biol. (Paris) 53 (2005) 189-192
6. Ciarmiello A., Cannella M., Lastoria S., Simonelli M., Frati L., Rubinsztein D.C., and Squitieri F. Brain white-matter volume loss and glucose hypometabolism precede the clinical symptoms of Huntington's disease. J. Nucl. Med. 47 (2006) 215-222
7. Coleman M.P., and Perry V.H. Axon pathology in neurological disease: a neglected therapeutic target. Trends Neurosci. 25 (2002) 532-537
8. Coleman M.P., Adalbert R., and Beirowski B. Neuroprotective strategies in MS: lessons from C57BL/Wld(S) mice. J. Neurol. Sci. 233 (2005) 133-138
9. Cowan C.M., and Raymond L.A. Selective neuronal degeneration in Huntington's disease. Curr. Top. Dev. Biol. 75 (2006) 25-71
10. Davies S.W., Turmaine M., Cozens B.A., DiFiglia M., Sharp A.H., Ross C.A., Scherzinger E., Wanker E.E., Mangiarini L., and Bates G.P. Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell 90 (1997) 537-548
11. DiFiglia M., Sapp E., Chase K.O., Davies S.W., Bates G.P., Vonsattel J.P., and Aronin N. Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 277 (1997) 1990-1993
12. Fennema-Notestine C., Archibald S.L., Jacobson M.W., Corey-Bloom J., Paulsen J.S., Peavy G.M., Gamst A.C., Hamilton J.M., Salmon D.P., and Jernigan T.L. In vivo evidence of cerebellar atrophy and cerebral white matter loss in Huntington disease. Neurology 63 (2004) 989-995
13. Ferrante R.J., Kowall N.W., and Richardson Jr. E.P. Proliferative and degenerative changes in striatal spiny neurons in Huntington's disease: a combined study using the section-Golgi method and calbindin D28k immunocytochemistry. J. Neurosci. 11 (1991) 3877-3887
14. Ferri A., Sanes J.R., Coleman M.P., Cunningham J.M., and Kato A.C. Inhibiting axon degeneration and synapse loss attenuates apoptosis and disease progression in a mouse model of motoneuron disease. Curr. Biol. 13 (2003) 669-673
15. Fischer L.R., Culver D.G., Davis A.A., Tennant P., Wang M., Coleman M., Asress S., Adalbert R., Alexander G.M., and Glass J.D. The WldS gene modestly prolongs survival in the SOD1G93A fALS mouse. Neurobiol. Dis. 19 (2005) 293-300
16. Guidetti P., Charles V., Chen E.Y., Reddy P.H., Kordower J.H., Whetsell Jr. W.O., Schwarcz R., and Tagle D.A. Early degenerative changes in transgenic mice expressing mutant huntingtin involve dendritic abnormalities but no impairment of mitochondrial energy production. Exp. Neurol. 169 (2001) 340-350
17. Gunawardena S., and Goldstein L.S. Polyglutamine diseases and transport problems: deadly traffic jams on neuronal highways. Arch. Neurol. 62 (2005) 46-51
18. Gunawardena S., Her L.S., Brusch R.G., Laymon R.A., Niesman I.R., Gordesky-Gold B., Sintasath L., Bonini N.M., and Goldstein L.S. Disruption of axonal transport by loss of huntingtin or expression of pathogenic polyQ proteins in Drosophila. Neuron 40 (2003) 25-40
19. Gundersen H.J. Stereology of arbitrary particles. A review of unbiased number and size estimators and the presentation of some new ones, in memory of William R. Thompson. J. Microsc. 143 (1986) 3-45
20. Hafezparast M., Klocke R., Ruhrberg C., Marquardt A., Ahmad-Annuar A., Bowen S., Lalli G., Witherden A.S., Hummerich H., Nicholson S., Morgan P.J., Oozageer R., Priestley J.V., Averill S., King V.R., Ball S., Peters J., Toda T., Yamamoto A., Hiraoka Y., Augustin M., Korthaus D., Wattler S., Wabnitz P., Dickneite C., Lampel S., Boehme F., Peraus G., Popp A., Rudelius M., Schlegel J., Fuchs H., Hrabe de Angelis M., Schiavo G., Shima D.T., Russ A.P., Stumm G., Martin J.E., and Fisher E.M. Mutations in dynein link motor neuron degeneration to defects in retrograde transport. Science 300 (2003) 808-812
21. Klapstein G.J., Fisher R.S., Zanjani H., Cepeda C., Jokel E.S., Chesselet M.F., and Levine M.S. Electrophysiological and morphological changes in striatal spiny neurons in R6/2 Huntington's disease transgenic mice. J. Neurophysiol. 86 (2001) 2667-2677
22. Kuhn A., Goldstein D.R., Hodges A., Strand A.D., Sengstag T., Kooperberg C., Becanovic K., Pouladi M.A., Sathasivam K., Cha J.H., Hannan A.J., Hayden M.R., Leavitt B.R., Dunnett S.B., Ferrante R.J., Albin R., Shelbourne P., Delorenzi M., Augood S.J., Faull R.L., Olson J.M., Bates G.P., Jones L., and Luthi-Carter R. Mutant huntingtin's effects on striatal gene expression in mice recapitulate changes observed in human Huntington's disease brain and do not differ with mutant huntingtin length or wild-type huntingtin dosage. Hum. Mol. Genet. 16 (2007) 1845-1861
23. LaMonte B.H., Wallace K.E., Holloway B.A., Shelly S.S., Ascano J., Tokito M., Van Winkle T., Howland D.S., and Holzbaur E.L. Disruption of dynein/dynactin inhibits axonal transport in motor neurons causing late-onset progressive degeneration. Neuron 34 (2002) 715-727
24. Lee W.C., Yoshihara M., and Littleton J.T. Cytoplasmic aggregates trap polyglutamine-containing proteins and block axonal transport in a Drosophila model of Huntington's disease. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 3224-3229
25. Levine M.S., Cepeda C., Hickey M.A., Fleming S.M., and Chesselet M.F. Genetic mouse models of Huntington's and Parkinson's diseases: illuminating but imperfect. Trends Neurosci. 27 (2004) 691-697
26. Li H., Li S.H., Cheng A.L., Mangiarini L., Bates G.P., and Li X.J. Ultrastructural localization and progressive formation of neuropil aggregates in Huntington's disease transgenic mice. Hum. Mol. Genet. 8 (1999) 1227-1236
27. Li H., Li S.H., Yu Z.X., Shelbourne P., and Li X.J. Huntingtin aggregate-associated axonal degeneration is an early pathological event in Huntington's disease mice. J. Neurosci. 21 (2001) 8473-8481
28. Liebermann A.R. A review of the principal features of perikaryal responses to axon injury. Int. Rev. Neurobiol. 14 (1971) 49-124
29. Lione L.A., Carter R.J., Hunt M.J., Bates G.P., Morton A.J., and Dunnett S.B. Selective discrimination learning impairments in mice expressing the human Huntington's disease mutation. J. Neurosci. 19 (1999) 10428-10437
30. Luo L., and O'Leary D.D. Axon retraction and degeneration in development and disease. Annu. Rev. Neurosci. 28 (2005) 127-156
31. Mangiarini L., Sathasivam K., Mahal A., Mott R., Seller M., and Bates G.P. Instability of highly expanded CAG repeats in mice transgenic for the Huntington's disease mutation. Nat. Genet. 15 (1997) 197-200
32. Morton A.J., Lagan M.A., Skepper J.N., and Dunnett S.B. Progressive formation of inclusions in the striatum and hippocampus of mice transgenic for the human Huntington's disease mutation. J. Neurocytol. 29 (2000) 679-702
33. Parker J.A., Connolly J.B., Wellington C., Hayden M., Dausset J., and Neri C. Expanded polyglutamines in Caenorhabditis elegans cause axonal abnormalities and severe dysfunction of PLM mechanosensory neurons without cell death. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 13318-13323
34. Raff M.C., Whitmore A.V., and Finn J.T. Axonal self-destruction and neurodegeneration. Science 296 (2002) 868-871
35. Reading S.A., Dziorny A.C., Peroutka L.A., Schreiber M., Gourley L.M., Yallapragada V., Rosenblatt A., Margolis R.L., Pekar J.J., Pearlson G.D., Aylward E., Brandt J., Bassett S.S., and Ross C.A. Functional brain changes in presymptomatic Huntington's disease. Ann. Neurol. 55 (2004) 879-883
36. Ribchester R.R., Thomson D., Wood N.I., Hinks T., Gillingwater T.H., Wishart T.M., Court F.A., and Morton A.J. Progressive abnormalities in skeletal muscle and neuromuscular junctions of transgenic mice expressing the Huntington's disease mutation. Eur. J. Neurosci. 20 (2004) 3092-3114
37. Rosas H.D., Liu A.K., Hersch S., Glessner M., Ferrante R.J., Salat D.H., van der Kouwe A., Jenkins B.G., Dale A.M., and Fischl B. Regional and progressive thinning of the cortical ribbon in Huntington's disease. Neurology 58 (2002) 695-701
38. Sapp E., Schwarz C., Chase K., Bhide P.G., Young A.B., Penney J., Vonsattel J.P., Aronin N., and DiFiglia M. Huntingtin localization in brains of normal and Huntington's disease patients. Ann. Neurol. 42 (1997) 604-612
39. Sapp E., Penney J., Young A., Aronin N., Vonsattel J.P., and DiFiglia M. Axonal transport of N-terminal huntingtin suggests early pathology of corticostriatal projections in Huntington disease. J. Neuropathol. Exp. Neurol. 58 (1999) 165-173
40. Smith P.M., and Jeffery N.D. Histological and ultrastructural analysis of white matter damage after naturally-occurring spinal cord injury. Brain Pathol. 16 (2006) 99-109
41. Smith R., Chung H., Rundquist S., Maat-Schieman M.L., Colgan L., Englund E., Liu Y.J., Roos R.A., Faull R.L., Brundin P., and Li J.Y. Cholinergic neuronal defect without cell loss in Huntington's disease. Hum. Mol. Genet. 15 (2006) 3119-3131
42. Stack E.C., Kubilus J.K., Smith K., Cormier K., Del Signore S.J., Guelin E., Ryu H., Hersch S.M., and Ferrante R.J. Chronology of behavioral symptoms and neuropathological sequela in R6/2 Huntington's disease transgenic mice. J. Comp. Neurol. 490 (2005) 354-370
43. Thieben M.J., Duggins A.J., Good C.D., Gomes L., Mahant N., Richards F., McCusker E., and Frackowiak R.S. The distribution of structural neuropathology in pre-clinical Huntington's disease. Brain 125 (2002) 1815-1828
44. Tippett L.J., Waldvogel H.J., Thomas S.J., Hogg V.M., van Roon-Mom W., Synek B.J., Graybiel A.M., and Faull R.L. Striosomes and mood dysfunction in Huntington's disease. Brain 130 (2007) 206-221
45. Tobin A.J., and Signer E.R. Huntington's disease: the challenge for cell biologists. Trends Cell Biol. 10 (2000) 531-536
46. Trushina E., Dyer R.B., Badger II J.D., Ure D., Eide L., Tran D.D., Vrieze B.T., Legendre-Guillemin V., McPherson P.S., Mandavilli B.S., Van Houten B., Zeitlin S., McNiven M., Aebersold R., Hayden M., Parisi J.E., Seeberg E., Dragatsis I., Doyle K., Bender A., Chacko C., and McMurray C.T. Mutant huntingtin impairs axonal trafficking in mammalian neurons in vivo and in vitro. Mol. Cell. Biol. 24 (2004) 8195-8209
47. Turmaine M., Raza A., Mahal A., Mangiarini L., Bates G.P., and Davies S.W. Nonapoptotic neurodegeneration in a transgenic mouse model of Huntington's disease. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 8093-8097
48. Zuccato C., and Cattaneo E. Role of brain-derived neurotrophic factor in Huntington's disease. Prog. Neurobiol. 81 (2007) 294-330